Cargando…

A safety and efficacy analysis of direct-antiviral therapy in patients with chronic hepatitis C after renal transplantation

BACKGROUND: To explore the safety and efficacy of direct antiviral therapy in patients with hepatitis C virus (HCV) infection after renal transplantation. METHODS: We retrospectively reviewed the medical information of 15 cases of HCV(+) patients treated with direct antiviral therapy after renal tra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Guanghui, Ma, Junjie, Xu, Lu, Fang, Jiali, Zhang, Lei, Wu, Jialin, Lai, Xingqiang, Liu, Luhao, Xiong, Yunyi, Yin, Wei, Zhang, Tao, Zhang, Peng, Li, Li, Chen, Rongxin, Wang, Jiao, Chen, Zheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215012/ https://www.ncbi.nlm.nih.gov/pubmed/32420163 http://dx.doi.org/10.21037/tau.2020.01.05

Ejemplares similares

Reconstruction of the hepatic artery using the superior mesenteric artery for liver transplantation
por: Fang, Jiali, et al.
Publicado: (2020)

Simultaneous antegrade urography of the upper urinary tract and retrograde cystography combined with computed tomography imaging in the management of ureteral complications after renal transplantation
por: Zhang, Lei, et al.
Publicado: (2021)

Sex Differences in Fecal Microbiota Correlation With Physiological and Biochemical Indices Associated With End-Stage Renal Disease Caused by Immunoglobulin a Nephropathy or Diabetes
por: Zhang, Peng, et al.
Publicado: (2021)

Ex vivo removal of stones in donor kidneys by pyelotomy prior to renal transplantation: a single-center case series
por: Liu, Luhao, et al.
Publicado: (2022)

Effect of disseminated intravascular coagulation on donation after citizens’ death donor kidneys
por: Xu, Lu, et al.
Publicado: (2021)

Ablation of Basic Leucine Zipper Transcription Factor ATF-Like Potentiates Estradiol to Induce Atopic Dermatitis
por: Zhang, Peng, et al.
Publicado: (2022)

Identification of key pathways and genes in different types of chronic kidney disease based on WGCNA
por: Guo, Yuhe, et al.
Publicado: (2019)

Effects of Long Noncoding RNA HOXA-AS2 on the Proliferation and Migration of Gallbladder Cancer Cells
por: Zhang, Peng, et al.
Publicado: (2022)

Autologous bone marrow-derived mesenchymal stem cells for interstitial fibrosis and tubular atrophy: a pilot study
por: Zhang, Lei, et al.
Publicado: (2021)

Direct-acting antiviral agent efficacy and safety in renal transplant recipients with chronic hepatitis C virus infection: A PRISMA-compliant study
por: Chen, Keliang, et al.
Publicado: (2017)

Role of Direct Antiviral Agents in Treatment of Chronic Hepatitis C Infection in Renal Transplant Recipients
por: Sharma, Sourabh, et al.
Publicado: (2018)

Hepatitis C and renal transplantation in era of new antiviral agents
por: Salvadori, Maurizio, et al.
Publicado: (2018)

Different biopsy techniques for different pancreas graft locations after homolateral simultaneous pancreas-kidney transplantation
por: Zhang, Lei, et al.
Publicado: (2023)

Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection
por: Lin, Ming V., et al.
Publicado: (2016)

Direct-acting Antiviral in the Treatment of Chronic Hepatitis C: Bonuses and Challenges
por: Zeng, Haiyan, et al.
Publicado: (2020)

Blood unconjugated bilirubin and tacrolimus are negative predictors of specific cellular immunity in kidney transplant recipients after SAR-CoV-2 inactivated vaccination
por: Zhang, Lei, et al.
Publicado: (2023)

Prevalence of resistance-associated substitutions to direct-acting antiviral agents in hemodialysis and renal transplant patients infected with hepatitis C virus
por: Tavares, Rita Chelly Felix, et al.
Publicado: (2018)

Impairment of T cells' antiviral and anti-inflammation immunities may be critical to death from COVID-19
por: Zhang, Luhao, et al.
Publicado: (2021)

Efficacy and Safety of Sofosbuvir-Based Direct-Acting Antiviral Agents Treatment for Patients with Genotype 3/6 Hepatitis C Virus Infection
por: Mei, Yong-yu, et al.
Publicado: (2020)

Assessing the Safety of Direct-Acting Antiviral Agents for Hepatitis C
por: McGlynn, Elizabeth A., et al.
Publicado: (2019)

The New Direct Antiviral Agents and Hepatitis C in Thoracic Transplantation: Impact on Donors and Recipients
por: Gottlieb, Robert L., et al.
Publicado: (2018)

Direct-Acting Antiviral Therapy in Liver Transplant Patients With Hepatocellular Carcinoma and Hepatitis C
por: Tse, Chung Sang, et al.
Publicado: (2020)

Prevalence of resistance-associated substitutions to direct-acting antiviral agents in hemodialysis and renal transplant patients infected with hepatitis C virus [Erratum]
Publicado: (2018)

Efficacy and safety of combined directly acting antivirals for treatment of Chinese chronic hepatitis C patients in a real-world setting
por: Chen, Jian-Hong, et al.
Publicado: (2017)

Musculoskeletal Ultrasound Evaluates Renal Injury and Predicts Renal Outcome in Patients with Gout
por: Li, Ze, et al.
Publicado: (2022)

Antiviral treatment for chronic hepatitis B: Safety, effectiveness, and prognosis
por: Wu, Ya-Li, et al.
Publicado: (2019)

Successful combination of direct antiviral agents in liver-transplanted patients with recurrent hepatitis C virus
por: Rupp, Christian, et al.
Publicado: (2018)

Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates
por: Gadiparthi, Chiranjeevi, et al.
Publicado: (2018)

Recurrent hyperkalemia in patients with chronic kidney disease and hepatitis C treated with direct antiviral agents
por: Yan, Taotao, et al.
Publicado: (2019)

Effectiveness of direct-acting antivirals in maintenance hemodialysis patients complicated with chronic hepatitis C
por: Li, Chunhong, et al.
Publicado: (2020)

Current therapy for chronic hepatitis C: The role of direct-acting antivirals
por: Li, Guangdi, et al.
Publicado: (2017)

Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis
por: Zhang, Hang, et al.
Publicado: (2023)

Successful Antiviral Treatment with Direct-Acting Antivirals for Hepatitis C Virus Infection during Peritransplant Period in a Kidney Transplant Recipient
por: Varotti, Giovanni, et al.
Publicado: (2021)

Efficacy and safety of new direct-acting antivirals in kidney transplant recipients with chronic hepatitis C: a single-center study
por: Darema, Maria, et al.
Publicado: (2020)

Efficacy and Safety of Direct-Acting Antivirals in Kidney Transplantation From HCV-Viremic Donors to Negative Recipients: A Meta-Analysis
por: Feng, Zepei, et al.
Publicado: (2022)

IP-10 Interferes With the Antiviral Response of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection
por: Wang, Yadong, et al.
Publicado: (2022)

Factors Associated with the Refusal of Direct-Acting Antiviral Agents for the Treatment of Hepatitis C in Taiwan
por: Chang, Li-Jen, et al.
Publicado: (2022)

Safety and mortality outcomes for direct oral anticoagulants in renal transplant recipients
por: Firth, Christine, et al.
Publicado: (2023)

Assessment of Renal Function in Post-Liver Transplant HCV-Positive Patients Treated with Direct Acting Antivirals
por: Elzorkany, Khaled, et al.
Publicado: (2020)

Timing of Hepatitis C Virus Treatment in Liver Transplant Candidates in the Era of Direct-acting Antiviral Agents
por: Cholankeril, George, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7crhn5uectvekeqe0p2dfdevs3